ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

7 links0 made here, not in the record12 judgments2 judges (the rules as one: Rule based)1 record change seen
Claude Opus 5.5Rule basedRecord updated on ClinicalTrials.govReplaced, or read an older version
Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT03942328Modified Immune Cells(Autologous DendriticCells) and a Vaccine(Prevnar) Combined WithImmune CheckpointInhibition After High-DoseExternal Beam RadiationMayo ClinicPhase 1/Phase 2 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Oct 5 · ClinicalTrials.gov record · Version of 2026-10-05Version of 2026-10-05CONDITIONSCarcinoma, HepatocellularThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionCholangiocarcinomaThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSAtezolizumabIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 3 · Claude Opus 5.5 · Background · partnerNov 18 · Rule based · TestedBackground · partnerBevacizumabIntervention entry›Nov 3 · Claude Opus 5.5 · TestedNov 18 · Rule based · TestedTested13-valent pneumococcal vacc…Entry “Pneumococcal 13-valent Conjuga…›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundTherapeutic Autologous Dend…Intervention entry›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · BackgroundBackgroundDurvalumabIntervention entry›Nov 3 · Claude Opus 5.5 · BackgroundNov 18 · Rule based · TestedBackground

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Atezolizumab

From the registry record3 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Atezolizumab”the record gives no role
→judged→changed→changed
How the 3 judgments split33%of judgments with a known value say Background · partner
Background · partner · 1
Tested · 2

All judgments on this study

WhenLinkJudgeDecisionState
Oct 5The record itselfClinicalTrials.gov recordVersion of 2026-10-05Record change
Nov 3AtezolizumabClaude Opus 5.5TestedReplaced
Nov 3BevacizumabClaude Opus 5.5TestedCurrent
Nov 313-valent pneumococcal vaccineClaude Opus 5.5BackgroundCurrent
Nov 3Therapeutic Autologous Dendritic CellsClaude Opus 5.5BackgroundCurrent
Nov 3DurvalumabClaude Opus 5.5BackgroundCurrent
Nov 3AtezolizumabClaude Opus 5.5Background · partnerCurrent
Nov 18AtezolizumabRule based · role ruleTestedOverridden
Nov 18BevacizumabRule based · role ruleTestedAgrees
Nov 1813-valent pneumococcal vaccineRule based · role ruleBackgroundAgrees
Nov 18Therapeutic Autologous Dendritic CellsRule based · role ruleBackgroundAgrees
Nov 18DurvalumabRule based · role ruleTestedOverridden
As of nowCarcinoma, HepatocellularRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.